The Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio, recently announced the 2016 recipients of its Harrington Scholar-Innovator…
Articles by Ana de Barros, PhD
Ionis Pharmaceuticals, Inc. — formerly Isis Pharmaceuticals — announced the U.S. Food and Drug Administration (FDA) has approved its Orphan Drug Designation…
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing treatments for depression, cancer, and diseases like Huntington’s that involve the central…
Oxford Finance, LLC announced that it has finished helping Chosen Healthcare, which operates expert nursing facilities for a variety of illnesses…
A group of researchers from the University of Florida Health have discovered new information about Huntington’s disease, namely that…
Researchers at the German Center for Neurodegenerative Diseases (DZNE)Â in Bonn have tested a new substance that may lead to…
The Hereditary Disease Foundation (HDF) recently hosted a celebratory night, gathering close to 200 recognized names and raising $1.2 million to…
Psychiatric manifestations develop more often than previously thought in Huntington’s disease prodrome, according to findings of a recent study…
The Rutgers’ Human Genetics Institute of New Jersey, home to RUCDR Infinite Biologics — the world’s largest university-based biorepository — announced…
While moving is normal to healthy people, making even the smallest movements may seem a difficult task for those who suffer…